IL-13 in asthma and allergic disease: Asthma phenotypes and targeted therapies

Expert Panel Report 2: Guidelines for the Diagnosis and Management of Asthma

Program, P., & theDiagnosis, T. E. P. O. (1997) · Cited by 4,083

Interleukin-13: Central Mediator of Allergic Asthma

Wills-Karp, M., Luyimbazi, J., Xu, X., Schofield, B., Neben, T. Y., Karp, C. L., & Donaldson, D. D. (1998) · Science · doi:10.1126/science.282.5397.2258 · Cited by 2,617

Expert Panel Report 3 (EPR-3): Guidelines for the Diagnosis and Management of Asthma–Summary Report 2007

(2007) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2007.09.029 · Cited by 2,181

Identification of Asthma Phenotypes Using Cluster Analysis in the Severe Asthma Research Program

Moore, W. C., Meyers, D. A., Wenzel, S. E., Teague, W. G., Li, H., Li, X., D'Agostino, R., Castro, M., Curran-Everett, D., Fitzpatrick, A. M., et al. (2010) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200906-0896oc · Cited by 2,129

Cluster analysis and clinical asthma phenotypes

Haldar, P., Pavord, I. D., Shaw, D. E., Berry, M. A., Thomas, M., Brightling, C. E., Wardlaw, A. J., & Green, R. H. (2008) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200711-1754oc · Cited by 1,987

Mepolizumab and Exacerbations of Refractory Eosinophilic Asthma

Haldar, P., Brightling, C. E., Hargadon, B., Gupta, S., Monteiro, W., Sousa, A., Marshall, R. P., Bradding, P., Green, R. H., Wardlaw, A. J., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0808991 · Cited by 1,871

Requirement for IL-13 Independently of IL-4 in Experimental Asthma

Grünig, G., Warnock, M., Wakil, A. E., Venkayya, R., Brombacher, F., Rennick, D. M., Sheppard, D., Mohrs, M., Donaldson, D. D., Locksley, R. M., et al. (1998) · Science · doi:10.1126/science.282.5397.2261 · Cited by 1,849

T-helper Type 2–driven Inflammation Defines Major Subphenotypes of Asthma

Woodruff, P. G., Modrek, B., Choy, D. F., Jia, G., Abbas, A. R., Ellwanger, A., Arron, J. R., Koth, L. L., & Fahy, J. V. (2009) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200903-0392oc · Cited by 1,803

Asthma exacerbations and sputum eosinophil counts: a randomised controlled trial

Green, R. H., Brightling, C. E., McKenna, S., Hargadon, B., Parker, D., Bradding, P., Wardlaw, A. J., & Pavord, I. D. (2002) · The Lancet · doi:10.1016/s0140-6736(02)11679-5 · Cited by 1,755

Pulmonary expression of interleukin-13 causes inflammation, mucus hypersecretion, subepithelial fibrosis, physiologic abnormalities, and eotaxin production

Zhu, Z., Homer, R. J., Wang, Z., Chen, Q., Geba, G. P., Wang, J., Zhang, Y., & Elias, J. A. (1999) · Journal of Clinical Investigation · doi:10.1172/jci5909 · Cited by 1,719

Association of Asthma with Serum IgE Levels and Skin-Test Reactivity to Allergens

Burrows, B., Martinez, F. D., Halonen, M., Barbee, R. A., & Cline, M. G. (1989) · New England Journal of Medicine · doi:10.1056/nejm198902023200502 · Cited by 1,659

Lebrikizumab Treatment in Adults with Asthma

Corren, J., Lemanske, R. F., Hanania, N. A., Korenblat, P. E., Parsey, M. V., Arron, J. R., Harris, J. M., Scheerens, H., Wu, L. C., Su, Z., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1106469 · Cited by 1,514

Mepolizumab for Prednisone-Dependent Asthma with Sputum Eosinophilia

Nair, P., Pizzichini, M. M. M., Kjarsgaard, M., Inman, M. D., Efthimiadis, A., Pizzichini, E., Hargreave, F. E., & O'Byrne, P. M. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0805435 · Cited by 1,356

Evidence That Severe Asthma Can Be Divided Pathologically into Two Inflammatory Subtypes with Distinct Physiologic and Clinical Characteristics

WENZEL, S. E., SCHWARTZ, L. B., LANGMACK, E. L., HALLIDAY, J. L., TRUDEAU, J. B., GIBBS, R. L., & CHU, H. W. (1999) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.160.3.9812110 · Cited by 1,235

Human IL-25- and IL-33-responsive type 2 innate lymphoid cells are defined by expression of CRTH2 and CD161

Mjösberg, J. M., Trifari, S., Crellin, N. K., Peters, C. P., van Drunen, C. M., Piet, B., Fokkens, W. J., Cupedo, T., & Spits, H. (2011) · Nature Immunology · doi:10.1038/ni.2104 · Cited by 1,166

Use of Exhaled Nitric Oxide Measurements to Guide Treatment in Chronic Asthma

Smith, A. D., Cowan, J. O., Brassett, K. P., Herbison, G. P., & Taylor, D. R. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa043596 · Cited by 974

Inflammatory subtypes in asthma: Assessment and identification using induced sputum

SIMPSON, J. L., SCOTT, R., BOYLE, M. J., & GIBSON, P. G. (2006) · Respirology · doi:10.1111/j.1440-1843.2006.00784.x · Cited by 955

Interleukin-13 Induces Tissue Fibrosis by Selectively Stimulating and Activating Transforming Growth Factor β1

Lee, C. G., Homer, R. J., Zhu, Z., Lanone, S., Wang, X., Koteliansky, V., Shipley, J. M., Gotwals, P., Noble, P., Chen, Q., et al. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.194.6.809 · Cited by 940

Direct effects of interleukin-13 on epithelial cells cause airway hyperreactivity and mucus overproduction in asthma

Kuperman, D. A., Huang, X., Koth, L. L., Chang, G. H., Dolganov, G. M., Zhu, Z., Elias, J. A., Sheppard, D., & Erle, D. J. (2002) · Nature Medicine · doi:10.1038/nm734 · Cited by 937

Proceedings of the ATS Workshop on Refractory Asthma: Current Understanding, Recommendations, and Unanswered Questions

(2000) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.162.6.ats9-00 · Cited by 909

Respiratory effects of exposure to diesel traffic in persons with asthma

McCreanor, J., Cullinan, P., Nieuwenhuijsen, M. J., Stewart-Evans, J., Malliarou, E., Jarup, L., Harrington, R., Svartengren, M., Han, I.-K., Ohman-Strickland, P., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa071535 · Cited by 898

IL-13 signaling through the IL-13α2 receptor is involved in induction of TGF-β1 production and fibrosis

Fichtner-Feigl, S., Strober, W., Kawakami, K., Puri, R. K., & Kitani, A. (2006) · Nature Medicine · doi:10.1038/nm1332 · Cited by 889

Randomized Trial of Omalizumab (Anti-IgE) for Asthma in Inner-City Children

Busse, W. W., Morgan, W. J., Gergen, P. J., Mitchell, H. E., Gern, J. E., Liu, A. H., Gruchalla, R. S., Kattan, M., Teach, S. J., Pongracic, J. A., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1009705 · Cited by 884

Neutrophilic Inflammation in Severe Persistent Asthma

JATAKANON, A., UASUF, C., MAZIAK, W., LIM, S., CHUNG, K. F., & BARNES, P. J. (1999) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.160.5.9806170 · Cited by 851

Genome-wide profiling identifies epithelial cell genes associated with asthma and with treatment response to corticosteroids

Woodruff, P. G., Boushey, H. A., Dolganov, G. M., Barker, C. S., Yang, Y. H., Donnelly, S., Ellwanger, A., Sidhu, S. S., Dao-Pick, T. P., Pantoja, C., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0707413104 · Cited by 828

Acidic Mammalian Chitinase in Asthmatic Th2 Inflammation and IL-13 Pathway Activation

Zhu, Z., Zheng, T., Homer, R. J., Kim, Y.-K., Chen, N. Y., Cohn, L., Hamid, Q., & Elias, J. A. (2004) · Science · doi:10.1126/science.1095336 · Cited by 805

Periostin: A novel component of subepithelial fibrosis of bronchial asthma downstream of IL-4 and IL-13 signals

Takayama, G., Arima, K., Kanaji, T., Toda, S., Tanaka, H., Shoji, S., McKenzie, A. N. J., Nagai, H., Hotokebuchi, T., & Izuhara, K. (2006) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2006.02.046 · Cited by 674

IL-25 augments type 2 immune responses by enhancing the expansion and functions of TSLP-DC–activated Th2 memory cells

Wang, Y.-H., Angkasekwinai, P., Lu, N., Voo, K. S., Arima, K., Hanabuchi, S., Hippe, A., Corrigan, C. J., Dong, C., Homey, B., et al. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20070406 · Cited by 671

Inducible targeting of IL-13 to the adult lung causes matrix metalloproteinase– and cathepsin-dependent emphysema

Zheng, T., Zhu, Z., Wang, Z., Homer, R. J., Ma, B., Riese, R. J., Chapman, H. A., Shapiro, S. D., & Elias, J. A. (2000) · Journal of Clinical Investigation · doi:10.1172/jci10458 · Cited by 646

IL-33 amplifies both Th1- and Th2-type responses through its activity on human basophils, allergen-reactive Th2 cells, iNKT and NK Cells

Smithgall, M. D., Comeau, M. R., Park Yoon, B.-R., Kaufman, D., Armitage, R., & Smith, D. E. (2008) · International Immunology · doi:10.1093/intimm/dxn060 · Cited by 619

Determining asthma treatment by monitoring sputum cell counts: effect on exacerbations

Jayaram, L., Pizzichini, M. M., Cook, R. J., Boulet, L.-P., Lemière, C., Pizzichini, E., Cartier, A., Hussack, P., Goldsmith, C. H., Laviolette, M., et al. (2006) · European Respiratory Journal · doi:10.1183/09031936.06.00137704 · Cited by 603

Effect of an interleukin-4 variant on late phase asthmatic response to allergen challenge in asthmatic patients: results of two phase 2a studies

Wenzel, S., Wilbraham, D., Fuller, R., Getz, E. B., & Longphre, M. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61600-6 · Cited by 588

IL-33–Responsive Lineage−CD25+CD44hi Lymphoid Cells Mediate Innate Type 2 Immunity and Allergic Inflammation in the Lungs

Bartemes, K. R., Iijima, K., Kobayashi, T., Kephart, G. M., McKenzie, A. N., & Kita, H. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1102832 · Cited by 549

Molecular and Structural Basis of Cytokine Receptor Pleiotropy in the Interleukin-4/13 System

LaPorte, S. L., Juo, Z. S., Vaclavikova, J., Colf, L. A., Qi, X., Heller, N. M., Keegan, A. D., & Garcia, K. C. (2008) · Cell · doi:10.1016/j.cell.2007.12.030 · Cited by 517

Pathological features and inhaled corticosteroid response of eosinophilic and non-eosinophilic asthma

Berry, M., Morgan, A., Shaw, D. E., Parker, D., Green, R., Brightling, C., Bradding, P., Wardlaw, A. J., & Pavord, I. D. (2007) · Thorax · doi:10.1136/thx.2006.073429 · Cited by 483

A Large Subgroup of Mild-to-Moderate Asthma Is Persistently Noneosinophilic

McGrath, K. W., Icitovic, N., Boushey, H. A., Lazarus, S. C., Sutherland, E. R., Chinchilli, V. M., & Fahy, J. V. (2012) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201109-1640oc · Cited by 478

Analyses of asthma severity phenotypes and inflammatory proteins in subjects stratified by sputum granulocytes

Hastie, A. T., Moore, W. C., Meyers, D. A., Vestal, P. L., Li, H., Peters, S. P., & Bleecker, E. R. (2010) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2010.02.008 · Cited by 463

Acute and chronic effects of cigarette smoking on exhaled nitric oxide.

Kharitonov, S. A., Robbins, R. A., Yates, D., Keatings, V, & Barnes, P. J. (1995) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.152.2.7543345 · Cited by 463

Heterogeneity of severe asthma in childhood: Confirmation by cluster analysis of children in the National Institutes of Health/National Heart, Lung, and Blood Institute Severe Asthma Research Program

Fitzpatrick, A. M., Teague, W. G., Meyers, D. A., Peters, S. P., Li, X., Li, H., Wenzel, S. E., Aujla, S., Castro, M., Bacharier, L. B., et al. (2011) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2010.11.015 · Cited by 446

Transcriptional regulation by STAT6

Goenka, S., & Kaplan, M. H. (2011) · Immunologic Research · doi:10.1007/s12026-011-8205-2 · Cited by 429

Asthma and Allergic Inflammation

Locksley, R. M. (2010) · Cell · doi:10.1016/j.cell.2010.03.004 · Cited by 408

Total Eosinophil Counts in the Management of Bronchial Asthma

Horn, B. R., Robin, E. D., Theodore, J., & Van Kessel, A. (1975) · New England Journal of Medicine · doi:10.1056/nejm197505292922204 · Cited by 393

Roles of epithelial cell-derived periostin in TGF-β activation, collagen production, and collagen gel elasticity in asthma

Sidhu, S. S., Yuan, S., Innes, A. L., Kerr, S., Woodruff, P. G., Hou, L., Muller, S. J., & Fahy, J. V. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1009426107 · Cited by 384

Measurements of exhaled nitric oxide in healthy subjects age 4 to 17 years

Buchvald, F., Baraldi, E., Carraro, S., Gaston, B., De Jongste, J., Pijnenburg, M. W. H., Silkoff, P. E., & Bisgaard, H. (2005) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2005.03.020 · Cited by 377

Neutrophil degranulation and cell lysis is associated with clinical severity in virus-induced asthma

Wark, P. A. B., Johnston, S. L., Moric, I., Simpson, J. L., Hensley, M. J., & Gibson, P. G. (2002) · European Respiratory Journal · doi:10.1183/09031936.02.00226302 · Cited by 373

IL-13 expression at the sites of allergen challenge in patients with asthma

Huang, S. K., Xiao, H. Q., Kleine-Tebbe, J., Paciotti, G., Marsh, D. G., Lichtenstein, L. M., & Liu, M. C. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.155.5.2688 · Cited by 371

A systematic review and meta-analysis: tailoring asthma treatment on eosinophilic markers (exhaled nitric oxide or sputum eosinophils)

Petsky, H. L., Cates, C. J., Lasserson, T. J., Li, A. M., Turner, C., Kynaston, J. A., & Chang, A. B. (2012) · Thorax · doi:10.1136/thx.2010.135574 · Cited by 338

Gene-Gene Interaction in Asthma: IL4RA and IL13 in a Dutch Population with Asthma

Howard, T. D., Koppelman, G. H., Xu, J., Zheng, S. L., Postma, D. S., Meyers, D. A., & Bleecker, E. R. (2002) · The American Journal of Human Genetics · doi:10.1086/338242 · Cited by 337

IL‐33‐activated dendritic cells are critical for allergic airway inflammation

Besnard, A., Togbe, D., Guillou, N., Erard, F., Quesniaux, V., & Ryffel, B. (2011) · European Journal of Immunology · doi:10.1002/eji.201041033 · Cited by 331

Relationship of exhaled nitric oxide to clinical and inflammatory markers of persistent asthma in children

Strunk, R. C., Szefler, S. J., Phillips, B. R., Zeiger, R. S., Chinchilli, V. M., Larsen, G., Hodgdon, K., Morgan, W., Sorkness, C. A., & Lemanske, R. F. (2003) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2003.08.014 · Cited by 327

Allergen-induced late asthmatic reactions are associated with elevation of exhaled nitric oxide.

Kharitonov, S. A., O'Connor, B. J., Evans, D. J., & Barnes, P. J. (1995) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.151.6.7767537 · Cited by 326

Airway inflammation is augmented by obesity and fatty acids in asthma

Scott, H. A., Gibson, P. G., Garg, M. L., & Wood, L. G. (2011) · European Respiratory Journal · doi:10.1183/09031936.00139810 · Cited by 325

Standardised methodology of sputum induction and processing

Djukanović, R., Sterk, P. J., Fahy, J. V., & Hargreave§, F. E. (2002) · European Respiratory Journal · doi:10.1183/09031936.02.00000102 · Cited by 324

The murine IL-13 receptor alpha 2: molecular cloning, characterization, and comparison with murine IL-13 receptor alpha 1.

Donaldson, D. D., Whitters, M. J., Fitz, L. J., Neben, T. Y., Finnerty, H. F., Henderson, S. L., O'Hara, R. M., Beier, D. R., Turner, K. J., Wood, C. R., et al. (1998) · PubMed · Cited by 321

The use of exhaled nitric oxide concentration to identify eosinophilic airway inflammation: an observational study in adults with asthma

Berry, M. A., Shaw, D. E., Green, R. H., Brightling, C. E., Wardlaw, A. J., & Pavord, I. D. (2005) · Clinical & Experimental Allergy · doi:10.1111/j.1365-2222.2005.02314.x · Cited by 318

Genome-wide association study of asthma identifies RAD50-IL13 and HLA-DR/DQ regions

Li, X., Howard, T. D., Zheng, S. L., Haselkorn, T., Peters, S. P., Meyers, D. A., & Bleecker, E. R. (2010) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2009.11.018 · Cited by 318

Pediatric severe asthma is characterized by eosinophilia and remodeling without TH2 cytokines

Bossley, C. J., Fleming, L., Gupta, A., Regamey, N., Frith, J., Oates, T., Tsartsali, L., Lloyd, C. M., Bush, A., & Saglani, S. (2012) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2012.01.059 · Cited by 316

IL-13 induces eosinophil recruitment into the lung by an IL-5– and eotaxin-dependent mechanism

Pope, S. M., Brandt, E. B., Mishra, A., Hogan, S. P., Zimmermann, N., Matthaei, K. I., Foster, P. S., & Rothenberg, M. E. (2001) · Journal of Allergy and Clinical Immunology · doi:10.1067/mai.2001.118600 · Cited by 314

Effects of steroid therapy on inflammatory cell subtypes in asthma

Cowan, D. C., Cowan, J. O., Palmay, R., Williamson, A., & Taylor, D. R. (2010) · Thorax · doi:10.1136/thx.2009.126722 · Cited by 310

The Interleukin 13 (IL-13) Pathway in Human Macrophages Is Modulated by MicroRNA-155 via Direct Targeting of Interleukin 13 Receptor α1 (IL13Rα1)

Martinez-Nunez, R. T., Louafi, F., & Sanchez-Elsner, T. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.169367 · Cited by 308

Abrogation of Bronchial Eosinophilic Inflammation and Airway Hyperreactivity in Signal Transducers and Activators of Transcription (STAT)6-deficient Mice

Akimoto, T., Numata, F., Tamura, M., Takata, Y., Higashida, N., Takashi, T., Takeda, K., & Akira, S. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.187.9.1537 · Cited by 304

A Randomized, Controlled, Phase 2 Study of AMG 317, an IL-4Rα Antagonist, in Patients with Asthma

Corren, J., Busse, W., Meltzer, E. O., Mansfield, L., Bensch, G., Fahrenholz, J., Wenzel, S. E., Chon, Y., Dunn, M., Weng, H. H., et al. (2010) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200909-1448oc · Cited by 299

Transcriptional phenotypes of asthma defined by gene expression profiling of induced sputum samples

Baines, K. J., Simpson, J. L., Wood, L. G., Scott, R. J., & Gibson, P. G. (2011) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2010.10.024 · Cited by 298

Periostin facilitates eosinophil tissue infiltration in allergic lung and esophageal responses

Blanchard, C., Mingler, M. K., McBride, M., Putnam, P. E., Collins, M. H., Chang, G., Stringer, K., Abonia, J. P., Molkentin, J. D., & Rothenberg, M. E. (2008) · Mucosal Immunology · doi:10.1038/mi.2008.15 · Cited by 280

The Murine IL-13 Receptor α2: Molecular Cloning, Characterization, and Comparison with Murine IL-13 Receptor α1

Donaldson, D. D., Whitters, M. J., Fitz, L. J., Neben, T. Y., Finnerty, H., Henderson, S. L., O’Hara, R. M., Beier, D. R., Turner, K. J., Wood, C. R., et al. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.5.2317 · Cited by 277

Cloning and Characterization of a Specific Interleukin (IL)-13 Binding Protein Structurally Related to the IL-5 Receptor α Chain

Caput, D., Laurent, P., Kaghad, M., Lelias, J.-M., Lefort, S., Vita, N., & Ferrara, P. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.28.16921 · Cited by 274

Use of Exhaled Nitric Oxide Measurement to Identify a Reactive, at-Risk Phenotype among Patients with Asthma

Dweik, R. A., Sorkness, R. L., Wenzel, S., Hammel, J., Curran-Everett, D., Comhair, S. A. A., Bleecker, E., Busse, W., Calhoun, W. J., Castro, M., et al. (2010) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200905-0695oc · Cited by 270

The Contribution of Interleukin (IL)-4 and IL-13 to the Epithelial–Mesenchymal Trophic Unit in Asthma

Richter, A., Puddicombe, S. M., Lordan, J. L., Bucchieri, F., Wilson, S. J., Djukanović, R., Dent, G., Holgate, S. T., & Davies, D. E. (2001) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/ajrcmb.25.3.4437 · Cited by 266

IL-13 and Epidermal Growth Factor Receptor Have Critical but Distinct Roles in Epithelial Cell Mucin Production

Zhen, G., Park, S. W., Nguyenvu, L. T., Rodriguez, M. W., Barbeau, R., Paquet, A. C., & Erle, D. J. (2007) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2006-0180oc · Cited by 248

Comparison of samples collected by sputum induction and bronchoscopy from asthmatic and healthy subjects.

Fahy, J. V., Wong, H., Liu, J., & Boushey, H. A. (1995) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.152.1.7599862 · Cited by 247

Mast cells produce interleukin-25 upon FcεRI-mediated activation

Ikeda, K., Nakajima, H., Suzuki, K., Kagami, S.-I., Hirose, K., Suto, A., Saito, Y., & Iwamoto, I. (2003) · Blood · doi:10.1182/blood-2002-09-2817 · Cited by 240

Effects of Interleukin-13 Blockade on Allergen-induced Airway Responses in Mild Atopic Asthma

Gauvreau, G. M., Boulet, L.-P., Cockcroft, D. W., FitzGerald, J. M., Carlsten, C., Davis, B. E., Deschesnes, F., Duong, M., Durn, B. L., Howie, K. J., et al. (2011) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201008-1210oc · Cited by 230

Biochemical reaction products of nitric oxide as quantitative markers of primary pulmonary hypertension

KANEKO, F. T., ARROLIGA, A. C., DWEIK, R. A., COMHAIR, S. A., LASKOWSKI, D., OPPEDISANO, R., THOMASSEN, M. J., & ERZURUM, S. C. (1998) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.158.3.9802066 · Cited by 228

IL‐13 induced increases in nitrite levels are primarily driven by increases in inducible nitric oxide synthase as compared with effects on arginases in human primary bronchial epithelial cells

Chibana, K., Trudeau, J. B., Mustovitch, A. T., Hu, H., Zhao, J., Balzar, S., Chu, H. W., & Wenzel, S. E. (2008) · Clinical & Experimental Allergy · doi:10.1111/j.1365-2222.2008.02969.x · Cited by 213

Smoking and Asthma

Boulet, L.-P., Catherine, L., Francine, A., Guy, C., Descary, M. C., & Francine, D. (2006) · Chest · doi:10.1378/chest.129.3.661 · Cited by 210

Fraction of Exhaled Nitric Oxide at 50 mL/s

Olin, A.-C., Bake, B., & Torén, K. (2007) · Chest · doi:10.1378/chest.06-2928 · Cited by 194

ANALYSIS OF NOVEL DISEASE-RELATED GENES IN BRONCHIAL ASTHMA

Yuyama, N., Davies, D. E., Akaiwa, M., Matsui, K., Hamasaki, Y., Suminami, Y., Yoshida, N. L., Maeda, M., Pandit, A., Lordan, J. L., et al. (2002) · Cytokine · doi:10.1006/cyto.2002.1972 · Cited by 194

Cooperative Effects of Th2 Cytokines and Allergen on Normal and Asthmatic Bronchial Epithelial Cells

Lordan, J. L., Bucchieri, F., Richter, A., Konstantinidis, A., Holloway, J. W., Thornber, M., Puddicombe, S. M., Buchanan, D., Wilson, S. J., Djukanović, R., et al. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.1.407 · Cited by 193

IL-13-Induced Chemokine Responses in the Lung: Role of CCR2 in the Pathogenesis of IL-13-Induced Inflammation and Remodeling

Zhu, Z., Ma, B., Zheng, T., Homer, R. J., Lee, C. G., Charo, I. F., Noble, P., & Elias, J. A. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.6.2953 · Cited by 188

Influence of atopy on exhaled nitric oxide in patients with stable asthma and rhinitis

Gratziou, C., Lignos, M., Dassiou, M., & Roussos, C. (1999) · European Respiratory Journal · doi:10.1034/j.1399-3003.1999.14d28.x · Cited by 183

Dose-Response Relationship and Reproducibility of the Fall in Exhaled Nitric Oxide After Inhaled Beclomethasone Dipropionate Therapy in Asthma Patients

Silkoff, P. E., McClean, P., Spino, M., Erlich, L. A., Slutsky, A. S., & Zamel, N. (2001) · Chest · doi:10.1378/chest.119.5.1322 · Cited by 182

Adenosine mediates IL-13–induced inflammation and remodeling in the lung and interacts in an IL-13–adenosine amplification pathway

Blackburn, M. R., Lee, C. G., Young, H. W. J., Zhu, Z., Chunn, J. L., Kang, M., Banerjee, S. K., & Elias, J. A. (2003) · Journal of Clinical Investigation · doi:10.1172/jci16815 · Cited by 182

Inhibition of human interleukin‐13‐induced respiratory and oesophageal inflammation by anti‐human‐interleukin‐13 antibody (CAT‐354)

Blanchard, C., Mishra, A., Saito‐Akei, H., Monk, P., Anderson, I., & Rothenberg, M. E. (2005) · Clinical & Experimental Allergy · doi:10.1111/j.1365-2222.2005.02299.x · Cited by 181

Mortality and Markers of Risk of Asthma Death Among 1,075 Outpatients With Asthma

Ulrik, C. S., & Frederiksen, J. (1995) · Chest · doi:10.1378/chest.108.1.10 · Cited by 176

Interleukin-13 Upregulates Eotaxin Expression in Airway Epithelial Cells by a STAT6-Dependent Mechanism

Matsukura, S., Stellato, C., Georas, S. N., Casolaro, V., Plitt, J. R., Miura, K., Kurosawa, S., Schindler, U., & Schleimer, R. P. (2001) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/ajrcmb.24.6.4351 · Cited by 169

Non-invasive markers of airway inflammation as predictors of oral steroid responsiveness in asthma

Little, S. A. (2000) · Thorax · doi:10.1136/thorax.55.3.232 · Cited by 169

Immunological and Clinical Changes in Allergic Asthmatics following Treatment with Omalizumab

Noga, O., Hanf, G., & Kunkel, G. (2003) · International Archives of Allergy and Immunology · doi:10.1159/000070434 · Cited by 168

Airway epithelial cells from asthmatic children differentially express proremodeling factors

Lopez-Guisa, J. M., Powers, C., File, D., Cochrane, E., Jimenez, N., & Debley, J. S. (2012) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2011.11.035 · Cited by 168

IL-13 stimulates vascular endothelial cell growth factor and protects against hyperoxic acute lung injury

Corne, J., Chupp, G., Lee, C. G., Homer, R. J., Zhu, Z., Chen, Q., Ma, B., Du, Y., Roux, F., McArdle, J., et al. (2000) · Journal of Clinical Investigation · doi:10.1172/jci9674 · Cited by 166

Haemophilus influenzae Infection Drives IL-17-Mediated Neutrophilic Allergic Airways Disease

Essilfie, A.-T., Simpson, J. L., Horvat, J. C., Preston, J. A., Dunkley, M. L., Foster, P. S., Gibson, P. G., & Hansbro, P. M. (2011) · PLoS Pathogens · doi:10.1371/journal.ppat.1002244 · Cited by 165

Gene Expression Patterns of Th2 Inflammation and Intercellular Communication in Asthmatic Airways

Choy, D. F., Modrek, B., Abbas, A. R., Kummerfeld, S., Clark, H. F., Wu, L. C., Fedorowicz, G., Modrusan, Z., Fahy, J. V., Woodruff, P. G., et al. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1002568 · Cited by 161

IL-4 receptor polymorphisms predict reduction in asthma exacerbations during response to an anti–IL-4 receptor α antagonist

Slager, R. E., Otulana, B., Hawkins, G. A., Yen, Y. P., Peters, S. P., Wenzel, S. E., Meyers, D. A., & Bleecker, E. R. (2012) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2012.03.030 · Cited by 158

Interleukin-4, Interleukin-13, Signal Transducer and Activator of Transcription Factor 6, and Allergic Asthma

Kuperman, D. A., & Schleimer, R. P. (2008) · Current Molecular Medicine · doi:10.2174/156652408785161032 · Cited by 157

Exhaled nitric oxide thresholds associated with a sputum eosinophil count >=3% in a cohort of unselected patients with asthma

Schleich, F., Seidel, L., Sele, J., Manise, M., Quaedvlieg, V., Michils, A., & Louis, R. (2010) · Thorax · doi:10.1136/thx.2009.124925 · Cited by 156

Total serum IgE and its association with asthma symptoms and allergic sensitization among children

Sherrill, D. L., Stein, R. T., Halonen, M. J., Holberg, C. J., Wright, A., & Martínez, F. D. (1999) · Journal of Allergy and Clinical Immunology · doi:10.1016/s0091-6749(99)70110-7 · Cited by 147

A Novel Role of Interleukin-13 Receptor α2 in Pancreatic Cancer Invasion and Metastasis

Fujisawa, T., Joshi, B. H., Nakajima, A., & Puri, R. K. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-2100 · Cited by 147

Interleukin-13 but Not Interleukin-4 Prolongs Eosinophil Survival and Induces Eosinophil Chemotaxis.

Horie, S., Okubo, Y., Hossain, M., Sato, E., NOMURA, H., Koyama, S., Suzuki, J.-I., Isobe, M., & Sekiguchi, M. (1997) · Internal Medicine · doi:10.2169/internalmedicine.36.179 · Cited by 138

ERK1/2 mitogen-activated protein kinase selectively mediates IL-13-induced lung inflammation and remodeling in vivo

Lee, C. G. (2005) · Journal of Clinical Investigation · doi:10.1172/jci25711 · Cited by 123

Use of sputum eosinophil counts to guide management in children with severe asthma

Fleming, L., Wilson, N., Regamey, N., & Bush, A. (2011) · Thorax · doi:10.1136/thx.2010.156836 · Cited by 122

Quantitative analysis of high-resolution computed tomography scans in severe asthma subphenotypes

Gupta, S., Siddiqui, S., Haldar, P., Entwisle, J. J., Mawby, D., Wardlaw, A. J., Bradding, P., Pavord, I. D., Green, R. H., & Brightling, C. E. (2010) · Thorax · doi:10.1136/thx.2010.136374 · Cited by 110

Preclinical development of CAT‐354, an IL‐13 neutralizing antibody, for the treatment of severe uncontrolled asthma

May, R. D., Monk, P., Cohen, E. S., Manuel, D. V. F. P., Dempsey, F. C., Davis, N. H. E., Dodd, A., Corkill, D. J., Woods, J. M., Joberty-Candotti, C., et al. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01659.x · Cited by 107

The role of IL-13 in IgE synthesis by allergic asthma patients

Kraan, T. C. T. M. V. D. P., van der Zee, J. S., Boeije, L. C. M., de Groot, E. R., Stapel, S. O., & Aarden, L. A. (1998) · Clinical & Experimental Immunology · doi:10.1046/j.1365-2249.1998.00471.x · Cited by 106

Role of Early Growth Response-1 (Egr-1) in Interleukin-13-induced Inflammation and Remodeling

Cho, S. J., Kang, M., Homer, R., Kang, H., Zhang, X., Lee, P. J., Elias, J. A., & Lee, C. G. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m506770200 · Cited by 104

Inflammatory Subtypes in Asthma are Related to Airway Hyperresponsiveness to Mannitol and Exhaled NO

Porsbjerg, C. M., Lund, T. K., Pedersen, L., & Backer, V. (2009) · Journal of Asthma · doi:10.1080/02770900903015654 · Cited by 104

Increased interleukin-13 mRNA expression in bronchoalveolar lavage cells of atopic patients with mild asthma after repeated low-dose allergen provocations

Prieto, J., Lensmar, C., Roquet, A., van der Ploeg, I., Gigliotti, D., Eklúnd, A., & Grünewald, J. (2000) · Respiratory Medicine · doi:10.1053/rmed.2000.0826 · Cited by 104

Exhaled Nitric Oxide Predicts Asthma Exacerbation

Harkins, M. S., Fiato, K.-L., & Iwamoto, G. K. (2004) · Journal of Asthma · doi:10.1081/jas-120033990 · Cited by 100

IL-13 receptor α 2: A regulator of IL-13 and IL-4 signal transduction in primary human fibroblasts

ANDREWS, A., Nasir, T., Bucchieri, F., Holloway, J. W., Holgate, S. T., & Davies, D. E. (2006) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2006.06.041 · Cited by 98

Strategy Aimed at Reduction of Sputum Eosinophils Decreases Exacerbation Rate in Patients with Asthma

Chlumský, J., Střı́ž, I., Teřl, M., & Vondráček, J. (2006) · Journal of International Medical Research · doi:10.1177/147323000603400202 · Cited by 97

Inhibition of Experimental Allergic Airways Disease by Local Application of a Cell-Penetrating Dominant-Negative STAT-6 Peptide

McCusker, C. T., Wang, Y., Shan, J., Kinyanjui, M. W., Villeneuve, A., Michael, H., & Fixman, E. D. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.4.2556 · Cited by 96

Provoked models of asthma: what have we learnt?

O’Byrne, P. M., Gauvreau, G. M., & Brannan, J. D. (2009) · Clinical & Experimental Allergy · doi:10.1111/j.1365-2222.2008.03172.x · Cited by 95

A protective role for periostin and TGF ‐β in IgE ‐mediated allergy and airway hyperresponsiveness

Gordon, E. D., Sidhu, S., Wang, Z., Woodruff, P. G., Yuan, S., Solon, M., Conway, S. J., Huang, X., Locksley, R. M., & Fahy, J. V. (2011) · Clinical & Experimental Allergy · doi:10.1111/j.1365-2222.2011.03840.x · Cited by 92

Interleukin‐13: prospects for new treatments

Brightling, C. E., Saha, S., & Hollins, F. (2009) · Clinical & Experimental Allergy · doi:10.1111/j.1365-2222.2009.03383.x · Cited by 90

Interleukin 13 and Interleukin 4 Receptor-α Polymorphisms in Rhinitis and Asthma

Bottema, R. W. B., Nolte, I. M., Howard, T. D., Koppelman, G. H., Dubois, A. E. J., de Meer, G., Kerkhof, M., Bleecker, E. R., Meyers, D. A., & Postma, D. S. (2010) · International Archives of Allergy and Immunology · doi:10.1159/000314366 · Cited by 90

IL-13 Receptor α2 Selectively Inhibits IL-13-Induced Responses in the Murine Lung

Zheng, T., Liu, W., Oh, S.-Y., Zhu, Z., Hu, B., Homer, R., Cohn, L. E., Grusby, M. J., & Elias, J. A. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.1.522 · Cited by 87

IL9 leads to airway inflammation by inducing IL13 expression in airway epithelial cells

Temann, U.-A., Laouar, Y., Eynon, E. E., Homer, R., & Flavell, R. A. (2006) · International Immunology · doi:10.1093/intimm/dxl117 · Cited by 86

A phase 1 study evaluating the pharmacokinetics, safety and tolerability of repeat dosing with a human IL-13 antibody (CAT-354) in subjects with asthma

Singh, D., Kane, B., Molfino, N. A., Faggioni, R., Roskos, L. K., & Woodcock, A. A. (2010) · BMC Pulmonary Medicine · doi:10.1186/1471-2466-10-3 · Cited by 84

Distinct epithelial gene expression phenotypes in childhood respiratory allergy

Giovannini‐Chami, L., Marcet, B., Moreilhon, C., Chevalier, B., Illie, M. I., Lebrigand, K., Robbe-Sermesant, K., Bourrier, T., Michiels, J., Mari, B. P., et al. (2011) · European Respiratory Journal · doi:10.1183/09031936.00070511 · Cited by 84

Mast cells express IL‐13Rα1: IL‐13 promotes human lung mast cell proliferation and FcɛRI expression

Kaur, D., Hollins, F., Woodman, L. B., Yang, W., Monk, P., May, R. D., Bradding, P. H., & Brightling, C. E. (2006) · Allergy · doi:10.1111/j.1398-9995.2006.01139.x · Cited by 81

IL-4, IL-13, and dexamethasone augment fibroblast proliferation in asthma

Kraft, M., Lewis, C. C., Pham, D. N., & Chu, H. W. (2001) · Journal of Allergy and Clinical Immunology · doi:10.1067/mai.2001.113760 · Cited by 79

The Predictive Value of IgE as Biomarker in Asthma

Alobaidi, A. H., Samarai, A. G. M. A., Samarai, A. K. Y. A., & M.Al-Janabi., J. (2008) · Journal of Asthma · doi:10.1080/02770900802126958 · Cited by 78

IL-11 Receptor α in the Pathogenesis of IL-13-Induced Inflammation and Remodeling

Chen, Q., Rabach, L. A., Noble, P. W., Zheng, T., Lee, C. G., Homer, R., & Elias, J. A. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.4.2305 · Cited by 73

Small Interfering RNA against Transcription Factor STAT6 Inhibits Allergic Airway Inflammation and Hyperreactivity in Mice

Darcan, Y., Meinicke, H., Fels, G., Hegend, O., Haberland, A., Kühl, A. A., Loddenkemper, C., Witzenrath, M., Kube, S., Henke, W., et al. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0713433 · Cited by 73

Dysregulation of the IL-13 Receptor System. A Novel Pathomechanism in Pulmonary Arterial Hypertension

Hecker, M., Zasłona, Z., Kwapiszewska, G., Niess, G., Zakrzewicz, A., Hergenreider, E., Wilhelm, J., Marsh, L. M., Sedding, D., Klepetko, W., et al. (2010) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200909-1367oc · Cited by 67

IL-13 Antibodies Influence IL-13 Clearance in Humans by Modulating Scavenger Activity of IL-13Rα2

Kasaian, M. T., Raible, D. G., Marquette, K., Cook, T. A., Zhou, S. Y., Tan, X., & Tchistiakova, L. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1100467 · Cited by 67

Modulation of Human Airway Smooth Muscle Migration by Lipid Mediators and Th-2 Cytokines

PARAMESWARAN, K. N., Radford, K., Fanat, A., Stephen, J., Bonnans, C., Levy, B. D., Janssen, L. J., & Cox, G. (2007) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2006-0172oc · Cited by 66

IL-13Rα2 Membrane and Soluble Isoforms Differ in Humans and Mice

Chen, W., Sivaprasad, U., Tabata, Y., Gibson, A. M., Stier, M. T., Finkelman, F. D., & Hershey, G. K. K. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0901028 · Cited by 65

STAT-1 is activated by IL-4 and IL-13 in multiple cell types

Wang, I.-M., Lin, H. M., Goldman, S. J., & Kobayashi, M. (2004) · Molecular Immunology · doi:10.1016/j.molimm.2004.04.027 · Cited by 64

Targeting IgE in asthma

Kuhl, K., & Hanania, N. A. (2011) · Current Opinion in Pulmonary Medicine · doi:10.1097/mcp.0b013e32834deebb · Cited by 61

Pulmonary type II cell hypertrophy and pulmonary lipoproteinosis are features of chronic IL-13 exposure

Homer, R. J., Zheng, T., Chupp, G. L., He, S., Zhu, Z., Chen, Q., Ma, B., Hite, R. D., Gobran, L. I., Rooney, S. A., et al. (2002) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00438.2001 · Cited by 58

A phase 1, randomized, placebo‐controlled, dose‐escalation study of an anti‐IL‐13 monoclonal antibody in healthy subjects and mild asthmatics

Hodsman, P., Ashman, C., Cahn, A. P., Boever, E. H. D., Locantore, N., Serone, A., & Pouliquen, I. J. (2012) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2012.04334.x · Cited by 57

Airway Fibroblasts in Asthma Manifest an Invasive Phenotype

Ingram, J. L., Huggins, M. J., Church, T. D., Li, Y., Francisco, D., Degan, S., Firszt, R., Beaver, D. M., Lugogo, N. L., Wang, Y., et al. (2011) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201009-1452oc · Cited by 56

Opposing Actions of Stat1 and Stat6 on IL-13-Induced Up-Regulation of Early Growth Response-1 and Platelet-Derived Growth Factor Ligands in Pulmonary Fibroblasts

Ingram, J. L., Antao-Menezes, A., Mangum, J. B., Lyght, O., Lee, P. J., Elias, J. A., & Bonner, J. C. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.6.4141 · Cited by 54

IL-13-induced proliferation of airway epithelial cells: mediation by intracellular growth factor mobilization and ADAM17

Booth, B. W., Sandifer, T. K., Martin, E. L., et al. (2007) · Respiratory Research · doi:10.1186/1465-9921-8-51 · Cited by 53

Asthma Phenotypes and Interleukin-13 — Moving Closer to Personalized Medicine

Kraft, M. (2011) · New England Journal of Medicine · doi:10.1056/nejme1108666 · Cited by 52

Exhaled breath condensate (EBC) biomarkers in pulmonary fibrosis

Chow, S., Thomas, P. S., Malouf, M. A., & Yates, D. H. (2012) · Journal of Breath Research · doi:10.1088/1752-7155/6/1/016004 · Cited by 49

Determinants of exhaled nitric oxide levels in healthy, nonsmoking African American adults

Levesque, M. C., Hauswirth, D. W., Mervin-Blake, S., Fernandez, C. A., Patch, K. B., Alexander, K. M., Allgood, S. D., McNair, P. D., Allen, A. S., & Sundy, J. S. (2007) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2007.09.031 · Cited by 43

Low levels of exhaled nitric oxide are associated with impaired lung function in cystic fibrosis

Keen, C., Gustafsson, P., Lindblad, A., Wennergren, G., & Olin, A. (2010) · Pediatric Pulmonology · doi:10.1002/ppul.21137 · Cited by 42

A novel and sensitive ELISA reveals that the soluble form of IL‐13R‐α2 is not expressed in plasma of healthy or asthmatic subjects

O’Toole, M., Legault, H. M., Ramsey, R., Wynn, T. A., & Kasaian, M. T. (2008) · Clinical & Experimental Allergy · doi:10.1111/j.1365-2222.2007.02921.x · Cited by 39

Association between Proximity to Major Roads and Sputum Cell Counts

Wallace, J., D’silva, L., Brannan, J. D., Hargreave, F. E., Kanaroglou, P., & Nair, P. K. (2011) · Canadian Respiratory Journal · doi:10.1155/2011/920734 · Cited by 38

Safety of omalizumab in asthma

Tan, R. A., & Corren, J. (2011) · Expert Opinion on Drug Safety · doi:10.1517/14740338.2011.563840 · Cited by 35

Role of 5-Lipoxygenase in IL-13-Induced Pulmonary Inflammation and Remodeling

Shim, Y. M., Zhu, Z., Zheng, T., Lee, C. G., Homer, R., Ma, B., & Elias, J. A. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.3.1918 · Cited by 34

IL13 variants are associated with total serum IgE and early sensitization to food allergens in children with atopic dermatitis

Zitnik, S. E., Rüschendorf, F., Müller, S., Sengler, C., Lee, Y., Griffioen, R. W., Meglio, P., Wahn, U., Witt, H., & Nickel, R. G. (2009) · Pediatric Allergy and Immunology · doi:10.1111/j.1399-3038.2008.00815.x · Cited by 33

The airway inflammatory response in allergic asthma and its relationship to clinical disease

Howarth, P. H. (1995) · Allergy · doi:10.1111/j.1398-9995.1995.tb02730.x · Cited by 32

Non-invasive assessment of exhaled biomarkers in lung transplantation

Yates, D. H., Krishnan, A., Chow, S., & Thomas, P. S. (2011) · Journal of Breath Research · doi:10.1088/1752-7155/5/2/024001 · Cited by 30

Neutrophilic inflammation is associated with altered airway hydration in stable asthmatics

Loughlin, C. E., Esther, C. R., Lazarowski, E. R., Alexis, N. E., & Peden, D. B. (2009) · Respiratory Medicine · doi:10.1016/j.rmed.2009.07.002 · Cited by 28

Th2 Cytokines IL-4 and IL-13 Downregulate Paxillin Expression in Bronchial Airway Epithelial Cells

Ramirez-Icaza, G., Mohammed, K. A., Nasreen, N., Horn, R. D. V., Hardwick, J. A., Sanders, K. L., Tian, J., Ramirez-Icaza, C., Johnson, M. T., & Antony, V. B. (2004) · Journal of Clinical Immunology · doi:10.1023/b:joci.0000029111.27168.c6 · Cited by 21

In moderate-to-severe asthma patients monitoring exhaled nitric oxide during exacerbation is not a good predictor of spirometric response to oral corticosteroid

Gelb, A. F., Moridzadeh, R. M., Singh, D. H., Fraser, C., & George, S. C. (2012) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2012.03.036 · Cited by 18

Genetic association studies of interleukin-13 receptor α1 subunit gene polymorphisms in asthma and atopy

Konstantinidis, A. K., Barton, S. J., Sayers, I., Yang, I. A., Lordan, J. L., Rorke, S., CLOUGH, J. B., Holgate, S. T., & Holloway, J. W. (2007) · European Respiratory Journal · doi:10.1183/09031936.00025706 · Cited by 18

Airway remodeling in asthma: what really matters

Fehrenbach, H., Wagner, C., & Wegmann, M. (2017) · Cell and Tissue Research · doi:10.1007/s00441-016-2566-8 · Cited by 406

Allergen-Induced Asthmatic Responses Modified by a GATA3-Specific DNAzyme

Krug, N., Hohlfeld, J. M., Kirsten, A.-M., Kornmann, O., Beeh, K. M., Kappeler, D., Korn, S., Ignatenko, S., Timmer, W., Rogon, C., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1411776 · Cited by 321

Current Understanding of Asthma Pathogenesis and Biomarkers

Habib, N., Pasha, M. A., & Tang, D. D. (2022) · Cells · doi:10.3390/cells11172764 · Cited by 299

Structural Basis of Signaling Blockade by Anti-IL-13 Antibody Lebrikizumab

Ultsch, M., Bevers, J., Nakamura, G., Vandlen, R., Kelley, R. F., Wu, L. C., & Eigenbrot, C. (2013) · Journal of Molecular Biology · doi:10.1016/j.jmb.2013.01.024 · Cited by 174

Asthma in the Precision Medicine Era: Biologics and Probiotics

Chiu, C.-J., & Huang, M.-T. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22094528 · Cited by 60